Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
8051 - 8060 of 8816 Results
Title
Year
  • Year
  • 2019
  • 2017
  • 2017
  • 2012
  • 2023
  • 2010
  • 2014
  • 2012
  • 2019
  • 2013
  • Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)
    2019
    Summary Details
    RESTRICTED
    Title: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)
    Author(s): Lana M. Chahine, Connie Marras, Margaret Daeschler, Steven Kahl, Robyn Rapoport, Arina Goyle, Chelle Precht, Catherine Kopil
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 92
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050
    Citation Count: 0
  • Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine
    2017
    Summary Details
    OPEN
    Title: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine
    Author(s): Steven M. Graves, Zhong Xie, Enrico Zampese, Kristen A. Stout, Rex Tai, Sarah E. Schwarzschild, Lena F. Burbulla, Dimitri Krainc, Paul T. Schumacker, D. James Surmeier
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Vol: 31
    Issue #: S1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3
    Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3
    Citation Count: 3
  • Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia
    2017
    Summary Details
    OPEN
    Title: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia
    Author(s): Andreas Dammann Andersen, Morten Blaabjerg, Michael Binzer, Akram Kamal, Helle Thagesen, Troels W. Kjær, Egon Stenager, Jan Bert Gramsbergen
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Vol: 141
    Issue #: 4
    Start Page: 614
    End Page: 625
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13997
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997
    Citation Count: 40
  • Alzheimer's disease: Pathogenesis and prevention
    2012
    Summary Details
    OPEN
    Title: Alzheimer's disease: Pathogenesis and prevention
    Author(s): Heiko Braak, Kelly Del Tredici
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 8
    Issue #: 3
    Start Page: 227
    End Page: 233
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2012.01.011
    Citation Count: 97
  • History of high household pesticide use and Parkinson's disease in Brazil
    2023
    Summary Details
    RESTRICTED
    Title: History of high household pesticide use and Parkinson's disease in Brazil
    Author(s): Dafne Dalledone Moura, Vanderci Borges, Henrique Ballalai Ferraz, Artur Francisco Schumacher Schuh, Carlos Roberto de Mello Rieder, Ignácio F. Mata, Manuelina Mariana Capellari Macruz Brito, Vítor Tumas, Bruno Lopes Santos‐Lobato
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 113
    Issue #:
    Start Page: 105493
    End Page: 105493
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105493
    Citation Count: 8
  • LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
    2010
    Summary Details
    OPEN
    Title: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
    Author(s): Rachel Saunders‐Pullman, Matthew J. Barrett, Kaili Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius, Susan Bressman
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: 15
    Start Page: 2536
    End Page: 2541
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23314
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978749
    Citation Count: 65
  • Fox Trial Finder, un nouvel outil pour la recherche clinique
    2014
    Summary Details
    RESTRICTED
    Title: Fox Trial Finder, un nouvel outil pour la recherche clinique
    Author(s): S. Villars, Leonardo Cappelletti, Włodzimierz Meissner
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Vol: 170
    Issue #:
    Start Page: A133
    End Page: A134
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360
    Citation Count: 0
  • Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study
    2012
    Summary Details
    RESTRICTED
    Title: Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study
    Author(s): Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martínez‐Martín, I Richard, S E Starkstein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 18
    Issue #: 10
    Start Page: 1084
    End Page: 1088
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.007
    Citation Count: 90
  • Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease
    2019
    Summary Details
    RESTRICTED
    Title: Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease
    Author(s): Anna Delamarre, François Tison, Qin Li, Monique Galitzky, Olivier Rascol, Erwan Bézard, Wassilios G. Meissner
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Vol: 126
    Issue #: 6
    Start Page: 789
    End Page: 793
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-019-02015-x
    Citation Count: 3
  • P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    2013
    Summary Details
    RESTRICTED
    Title: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    Author(s): Sylvie Ramboz, S. De Silva, Ralph W. Stevenson, Melville W. Osborne, M. Willms, Andrea E. Kudwa, Carla Cirillo, Richard Mushlin, Michael Olsen, Stephen J. Bent, Afshin Ghavami, Todd Sherer, Mark Frasier, Kuldip D. Dave
    Journal Name: Neuromuscular Disorders
    Publisher: Elsevier BV
    Vol: 23
    Issue #: 9-10
    Start Page: 836
    End Page: 836
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.